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Summary: A central problem in the study of the pathogenesis of liver fibrosis (fibrogenesis) is the identification
of the cellular sources of the extracellular matrix and the dissection of the molecular mediators stimulating
connective tissue synthesis in certain hepatic target cells. In the present study the role of platelets and of some
platelet-derived polypeptide growth factors in the proliferation and proteoglycan synthesis of rat liver fat
storing cells in culture (the principle connective tissue-producing cell type in liver) was determined. Fat storing
cell proliferation was determined by measurement of the DNA-content, and [3H]thymidine- and bromode-
oxyuridine-incorporation. Glycosaminoglycan synthesis was determined by the measurement of [35S]sulphate
incorporation.
Human platelet lysate (0.3 to 2.6 g protein per litre medium) stimulated, in a dose-dependent manner, both
the proliferation and glycosaminoglycan synthesis of rat liver fat storing cells kept äs a primary culture in
Dulbecco's modificätion of Eagle's medium in the absence of foetal calf serum. More than 70% of the newly
synthesized glycosaminoglycans were found in the medium. Among the various thrombocyte-derived poly-
peptides tested äs candidate mediators of the platelet-derived fibrogenic activity, platelet derived growth factor
was not effective in enhancing glycosaminoglycan synthesis, and it stimulated the proliferation of fat storing
.cells only about 2 fold. On the other hand, epidermal growth factor proved to be a Stimulus of both processes.
Transforming growth factor (> 10 pmol/1) inhibited foetal calf serum (Dulbecco's modificätion of Eagle's
medium with a fraction of foetal calf serum of 0.1) and epidermal growth factor stimulated proliferation but
enhanced the synthesis of sulphated glycosaminoglycans about 2-fold. These results suggest the possible role
of transforming growth factor äs a negative modulator for fat storing cells proliferation but a positive
modulator for fat storing cell transformation and extracellular glycosaminoglycan matrix synthesis. Further-
more, our results indicate a cpoperation between different hepatic and extrahepatic cell types by paracrine
Stimulation of fat storing cells. Transfonning growth factor in combination with epidermal growth factor
appear to be candidate mediators of the platelet-derived fibrogenic activity, which stimulates fat storing cells
in culture, and might also be effective in vivo during hepatic repair processes following liver injury.
Introduction
Persistent liver cell injury, irrespective of its aetiology, (ii) a molecular rearrangement of connective tissue
may be follpwed by liver fibrosiSj which is defined by composition, and
(i) an excess and irregulär deposition öf connective (iii) modifications of the fine structure of the various
tissue elements in the intercellular space, connective tissue molecules (1).
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The main components of human and animal liver
extracellular matrix are several types of collagens
(2 — 5), some structural glycoproteins (fibronectin,
laminin) (6), a group of proteoglycans (proteoheparan
sulphate, proteochondroitin sulphate, proteodefma-
tan (sulphate) (l, 7-9), the glycosaminoglycan, hy-
aluronic acid (7, 10), and elastin. In fibrotic liver the
concentration of all extracellular matrix elements, ex-
cept heparan sulphate, is elevated several-fold. The
cells responsible for producing the various connective
tissue components are hepatocytes, which synthesize
predominantly heparan sulphate, äs well äs fibronec-
tin, laminin (6) and potentially some collagens (2, 3)
and certain non-parenchymal liver cells (fat storing
cells, endothelial cells), which produce several extra-
cellular matrix components. Liver fat storing cells
attract increasing interest, because under certain con-
ditions fat storing cells proliferate strongly (4, 9, 11,
12) and transform into myofibroblast like cells (13).
These stain positively for the cytoskeletal protein,
desmin (14), and they produce significant quantities
of connective tissue components and, interestingly, a
pattern of glycosaminoglycans and collagen similar
to that found in fibrotic liver extracellular matrix (l,
4, 5, 7, 8, 15, 16). These reactions are considered to
be important events in human and animal liver fibro-
genesis (l, 5, 7, 10, 16-18). So far, little is known
about the factors (fibrogenic mediators) which pro-
mote proliferation/transformation and extracellular
matrix synthesis of fat storing cells. Recently, studies
from others and from our laboratory have shown that
secretions of activated Kupffer cells and monocytes
stimulated the proliferation/transformation of fat
storing cells in culture (9, 12), äs well äs stimulating
the synthesis of proteoglycans (16) and hyalurönic
acid (10) by these cells. Activated macrophages pro-
duce platelet derived growth factor, transforming
growth factor (19) and transforming growth factor
ß, all of which may be candidate mediators of mac-
rophage-derived fibrogenic actitiviy. The findings that
(i) an enhanced pool of platelets together with infil-
trated inflammatory cells are seen by electron mi-
croscopy in liver cell necrotic areas (20),
(ii) platelets are the riebest source of transforming
growth factor ßl (21, 22), and
(iii) platelet derived growth factor and the transform-
ing growth factor ot-like epidermal growth factor may
be released from alpha granules of platelets following
platelet activation (23), support the hypothesis that
thrombocytes might be involved in liver fibrogenesis
by stimulating the growth, transformation and extra-
cellular matrix synthesis of fat storing cells.
The purpose of this study was to isolate and cultivate
rat liver fat storing cells, in order to study the stim-
ulatory potency of human thrombocyte lysate and of
platelet derived growth factor, epidermäl growth fac-
tor and transforming growth factor on fat storing
cell proliferation/transformation and on glycosami-
noglycan synthesis. Our results indicate that
• t
(i) thrombocytes stimulate fat storing cell prölifera-
tion and the synthesis and secretion of sulphated
glycosaminoglycans by these cells,
(ii) transforming growth factor and epidermal




Thrombocyte concentrate was isolated by centrifugation at
300g (1500 min"1) (Fenwal CS-3000 cell Separator) from nor-
mal human donor blood. Human epidermal growth factor (ß-
urogastrone), collagenase H (clostridiopeptidase A, £C
3.4.24.3) and foetal calf serum were from Boehringer Mann-
heim, FRG. Transforming growth factor (source human plate-
lets) was purchased from ICN Biochemicals, Cleveland, Öhio,
USA. Monoclonal mouse antibodies to BrdUrd and nuclease
were from Amersham Buchler, Braunschweig, FRG.
[3H]thymidine (673 Tßq/niol) and [35S]sulphate (18.5-22.2
TBq/mol) were from New England Nuclear Corp., Boston,
Mass. USA and Nycpdenz (analyticai grade) was from Nye-
gaard and Co. AS, Oslo, Norway. Calf thyrnus DNA (type I),
pronase and platelet derived growth factor (source human pläte*
lets) were from Sigma Chemical Company, Munich, FRG.
Peroxidase-conjugated rabbit-anti-mpuse-iminunoglobulins
and antibodies to desmin and vimentin were purchased from
Dakopatts, Glostrup, Denmafk.
Preparation of thrombocyte lysate
Human thrombocyte concentrate (kindly supplied by Prof.
Kretschmer, Abt. f. Transfusionsmedizin, Universitätsklinik
Marburg) was lysed by sonification, centrifuged at 4 °C for 20
min at 3000 g and the supernatant was dialysed extensively (cüt
off Mc 3500) against Dulbecco*s modification ofEagle's medium
at 4 °C.
Cell isolation and cell culture
Detailed procedures for the Isolation and culture of fat storing
cells from rats have been published previously from this labö^
ratory (7^9, 16). Briefly, the cells were isolated from one year
old, 500 — 650 g male Sprague Dawley rats (Lippische Versuchs·?
tierzucht, Extertal, FRG). Non-parenchymal cells were isolated
by the pronase/collagenase method of de Leeuw et al. (4), äs
originally described by Knook et al. (24), with some minor
modifications described in detail elsewhere (8). They were puil··
fied by a single-step Nycodenz density gradient (82 g/l). The
cells were seeded at a density of 0.2—0.4 6 cells/2 cm2 on
24-well culture plates (Greiner, Nürtingen, FRG), or at a density
of 0.4 106 cells/10 cm2 on 6-well culture plates (Greiner,
Nürtingen, FRG)^ or at a density of 0.04-0.1 l O6 cells/cm2
on l cm2 glass cover slips. They were then grown in Dulbecco's
modification of Eagte's medium (Flow Laboratories GmbH,
Bonn, FRG) with 4 mmol/1 L-glutamine, 100 kU/1 peniciliin,
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a)
e)
Fig. l Microscopy of rat liver fat storing cells in priraary
culture.
a) Light microscopy 18 h after seeding (before 2nd
medium change). Seeding density was 0.02 χ l O6
cells/cm2. Fat storing cells show numerous lipid drop-
lets arround the nucleus. Magnification 75 χ .
b) Phase contrast microscopy of a single fat storing cell
on the 5th day of culture. The cell is flat and shows
long cellular extensions and residues of cytoplasraic
lipid droplets. Magnification 175 χ .
c) Indirect immunoperoxidase staining for desmin. Pri-
mary culture of fat storing cells grown in Dulbecco's
modification ofEagle's medium containing a fraction
of 0.1 foetal calf serum 8 days after seeding. About
70% of the cells are stained. Examples of desmin-
negative cells are indicated by an arrow. Seeding
density was 0.02 χ l O6 cells/cm2. Magnification
75x.
d) Phase contrast microscopy of the same cells s in flg.
Ic. Examples of desmin-negative cells are indicated
by an arrow. Magnification 75 χ.
e) Iridirect immunofiuorescence staining for viraentin.
Primary culture of fat storing cells grown in Dulbec-
co's modification of Eagle's medium with a fraction
of 0.1 foetal calf serum 6 days after seeding. Many
fibriis of virnentin are recognized in the cytoplasm.
Magnification I60x.
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100 mg/1 streptomycin and a fraction of 0.1 foetal calf serum
in a humidifled atmosphere of 0.05 CO2 and 0.95 air at 37 °C.
The purity of the fat storing cell preparations was assessed by
Lighl-microscopy (fig. l a), using the presence of perinuclear
lipid droplets and the typical cell shape s markers, and by
vitamin A-specific autofluorescence (8). At a later stage of the
culture, purity was assessed by phase contrast microscopy (fig.
l b) and by immunofluorescence/immunoperoxidase staining for
desmin (fig. Ic) and vimentin (fig. Id). The mean purity of
freshly isolated cells was greater than 85%, and cell viability
assessed by trypan blue exclusion was more than 80%. With
the first (about 8 h after seeding) and second (about 20 h after
seeding) medium change, most of the contaminating cells were
removed, and the fat storing cell monolayers were essentially
free from impurities. With the third medium change (about
44 h after seeding) foetal calf serum in Dulbecco's modification
of Eagle's medium was omitted and thrombocyte lysate (5—40
μΐ = 0.325—2.6 mg protein) was added. In experiments to
study the effects of platelet-derived growth factors, the frac-
tional content of foetal calf serum was decreased to 0.005 at
the third medium change, and test substances [platelet derived
growth factor (0.25 — 5 μg/l)3 epidermal growth factor (5 — 50
μg/l), and transforming growth factor β (0.025—6 μg/l)] were
added. Twenty four hours later, the medium was changed in
order to introduce radiolabelled precursors, and this new me-
dium also contained fresh Supplements of growth factors.
Determination of cell proliferatipn
DNA measurement
The DNA content of the fat storing cell monolayer (4 days
after seeding) was measured fluorometrically using calf thymus
DNA (type I, Sigma Chem. Co., Munich, FRG) s a Standard
(25).
[3H]Thymidine incorporation
Thymidine incorporation was measured after trichloroacetic
acid precipitation of cells, which had been exposed for 24 h to
[3H]thymidine (74 MBq/1 medium), beginning on the third day
after seeding (9).
740 MBq/1 medium) during a labelling period of 24 h [details
described elsewhere (7, 8, 16)]. Usually, the radionuclide was
added after a medium change on the 3rd day of primary cuiture.
Cultures were stopped by removing the medium, washing the
cell layer three times with phosphate buffered saline and freez-
ing the cells. The cells were detached from the well by repeated
(3 χ ) freezing and thawing and scraped off with a pipette tip.
Less than l % of the radioactivity remained in the well. Details
of the procedure to detennine the synthesis and secretion of
sulphated glycosaminoglycans are described elsewhere (8).
Briefly, glycosaminoglycans were isolated by binding to DEAE-
Sephacel (Pharmacia Fine Chemicals, Uppsala, Sweden), equi-
librated with 0.3 mol/1 sodium acetate buffer (pH 6.6), exten-
sively washed with the same buffer, and thereafter eluted with
2.2 mol/1 NaQ. An aliquot of the eluate was mixed with Instagel
(Packard Instruments Company, D wners Grove, 111., USA)
and c unted for radioactivity. Glycosaminoglycan synthesis was
expressed s radioactivity per mg DNA. In experiments using
thrombocyte lysate to stimulate fat storing cells, glycosamino-
glycans were measured separately in the medium and cell-layer
of the cultures. Glycosaminoglycans of the cell layer were
determined aftef proteolysis with papain (EC 3.4.22.2) s de-
scribed previously (8).
Results
Fat storing cell proliferation
Effect of thrombocyte lysate
Proliferation of fat storing cells in foetal calf ser m-
free medium was stim lated by thrombocyte lysate in
a dose dependent manner (fig. 2). [3H]thymidine in-
corporation and DNA content per culture were in-
creased to a maximum of 8- and 2-f ld, respectively,
48 h after the ddition of 40 μΐ (2.6 mg protein)
thrombocyte lysate to primary cultures of fat storing
cells grown n 10 cm2 wells in 2ml Dulbecco's m d-
Bromodeoxyuridine incorporation
To study BrdUrd incorporation, fat storing cells were seeded
at a density of 0.04-0.1 χ l O6 cells/cm2 in Dulbecco's modi-
fication of Eagle's medium containing a fraction of 0.1 foetal
calf serum on l cm2 glass cover slips in 6 well (3 ml/well)
macroplates (Greiner, N rtingen, FRG). Twenty four h after
seeding, foetal calf serum was decreased to 5 ml/1 medium, and
growth factors were added. Eighteen h before the end of the
culture, BrdUrd (50 μιηοΐ/ΐ final concentration) was added. At
the end of the culture period, monolayers were washed twice
with phosphate buffered saline-Dw/fecco's modification of Ea-
gle's medium (pH 7.4) and fixed with ethanol/acetic acid 95-1-5
(by vol.). DNA was then denatured by incubating the cells for
45 min at 37 °C with BrdUrd antibodies and nuclease. After
washing 3 times with phosphate buffered saline (pH 7.4) cells
were incubated with peroxidase-conjugated rabbit anti-mouse-
immunoglobulins for 45 min at 37 °C. Cells were then washed
again 3 times with phosphate buffered saune, and the nuclei,
which had taken up BrdUrd, were stained with 3,3'-diamino-
benzidine tetrahydrochloride s Substrate and hydrogen per-
oxide 3%, nickel Chloride and cobalt chloride 30 g/l in H2O s
intensifier.
Determination of the synthesis of total glycosami-
noglycans
The synthesis of sulphated glycosaminoglycans was determined
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Fig. 2. Proliferation of fat storing cells measured by incorpo-
ration of [3H]thymidine into DNA (a) and DNA content
per culture (b), Cells were labelled with j[3H]thymidme
(74 MBq/1) for 24 h between the 3rd and 4th culture
day.
Thrombocyte lysate (0.65-2.6 mg «protein/culture) was
added pn the second and third day after seeding. Cells
were seeded ata density of 0.1 χ lO'cells/cnoA Contrpl
cuiture received Dutbecco's modification of Eagle's ine-
dhrni without foetai calf serum. Mean values ± SD of
° three independent experiments, each with n = 4.
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ification of Eagle's medium without foetal calf serum.
If fat storing cells were cultured in Dulbecco's modi-
fication of Eagle's medium containing a fraction of
0.1 foetal calf serum, the addition of thrombocyte
lysate caused only a 2-fold Stimulation of [3H]thy-
midine incorporation and it had no significant effect
on the DNA content.
Epidermal growthfactor-stimulatedfat storing cell pro-
liferation
Incubation of subconfluent rat fat storing cells with
human epidermal growth factor in the presence of
5 ml/l foetal calf serum resulted in a dose-dependent
Stimulation of cell proliferation, s measured by
[3H]thymidine incorporation (fig. 3a), DNA content
per culture well (fig. 3b) and BrdUrd incorporation
(tab, 1). Twenty μg/l (3.3 nmol/1) epidermal growth
factor stimulated [3H]thymidine incorporation to a
maximum of 3.5-fold, compared with controls. The
EC50 for epidermal growth factor-stimulated
[3H]thymidine incorporation was calculated to be
about 8 μg/l (1.3 nmol/1) using 7 concentratioris of
epidermal growth factor ranging from 5 to 1000 μ%/1
Fifty μg/l epidermal growth factor produced maximal
DNA synthesis (fig. 3b). In the presence of a higher
foetal calf serum concentration (100 ml/l), epidermal
growth factor failed to stimulate fat storing cell pro-
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Fig. 3. Dpse-dependent Stimulation of fat storing cell prolifer-
ation measured by [3H]thymidine incorporation into
DNA (a) and DNA content (b) bym human epidermal
growth factor. Cells were seeded at a density of 0.06
χ 106 celis/cni2 in 6-well culture plates and grown in
Dulbecco's modification of Eagle's medium containing
a fraction of 0.005 foetal calf serum. Human epidermal
growth factor (1 — 50 μg/l) was added on the second
and third day after seeding.
Between the 3rd and 4th culture day cells were labelled
with [3H]thyimdine 74 MBq/1 medium for 24 h. Control
culture was kept in Dulbecco's modification pf Eagle's
medium containing a fraction of 0.005 foetal calf serum.
Mean values ± SD of three independent experiments.
each with n == 4.
Tab. 1. EfTect of foetal calf serum (PCS) and epidermal growth
factor (EGF) on fat storing cell proliferation.
Proliferation was measured by bromodeoxyuridine in-
corporation. Cells were seeded at a density of 0.06
χ l O6 cells/cm2 on glass cover slips in Dulbecco's mod-
ification of Eagle's medium (DMEM) containing a frac-
tion of 0.1 foetal calf serum. After 24 h the fraction of
foetal calf serum was reduced to 0.005, and epidermal
growth factor (5 ug/1 or 50 μg/l) was added. Eighteen
h before the end of the culture cells were labelled with
BrdUrd (5 χ 10~"5 mol/1 final concentration). Nuclei
which had taken up BrdUrd were stained by immu-
noperoxidase method using antibodies to BrdUrd. The
control represents Dulbecco's modification of Eagle's
medium containing a fraction of 0.005 foetal calf serum
(0.5% PCS).
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Effect of transforming growth factor β on fat storing
cell proliferation and transformation
Transforming growth factor β (0.025-2.5 μg/l,
1 — 100 pmol/1) inhibited, in a dose dependent manner,
the proliferation of fat storing cells grown in Dulbec-
co's modification of Eagle's medium containing a
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Fig. 4. Transforming growth factor -induced dose-dependent
Inhibition of fat storing cell proliferation measured by
[3H]thymidine incorporation into DNA (n —B) and
DNA content (e-·). Cells were seeded at a density of
0.06 χ l O6 cells/cm2 in 6-well culture plates and grown
in Dulbecc 's modification of Eagle's medium contain-
ing a fraction of 0.005 foetal calf serum [a] or in Dul-
becco's modification of Eagle's medium containing a
fraction of 0.1 foetal calf serum [b]. Transforming
growth factor β was added on the 2nd and 3rd day after
seeding. Between the 3rd and 4th culture day cells were
exposed for 24 h to [3H]thymidine 74 MBq/l medium.
Values represent mean ± SD of 4 cultures.
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the culture period was only 4 days, the Inhibition of
[3H]lhymidine incorporation was more pronounced
(significant reduction with 10 pmol/1 transfonning
growth factor ß) than the decrease of the DNA con-
tent (significant reduction with 100 pmol/1 transfonn-
ing growth factor ). higher transforming growth
factor concentration (6 g/l, 240 pmol/1), added on
second and third day after seeding to primary cultures
of rat fat storing cells (containing 0.005 foetal calf
serum) inhibited basal [3H]thymidine incorporation
by 90%, while epidermal growth factor (50 g/l, 9.1
nmol/1) stimulated cell proliferation by 92% (flg. 5).
In a further experiment, fat storing cells were seeded
at a density of 3000 cells/cm2 and grown in Dulbecco's
modification of Eagle's medium containing a fraction
of 0.1 foetal calf serum in the presence or absence of
20 pmol/1 transforming growth factor ß. Cultures were
stopped after 2, 6, 8, 14, 16 and 18 days. Total cell
numbers were counted using phase-contrast micros-
copy, and the fraction of desmin-positive cells was
counted after immunoperoxidase staining for desmin.
While inhibitijig cell growth, transforming growth
factor ß stimulated fat storing cell transformation to
desmin-positive myofibroblast-like cells (fig. 6).
Platelet derived growth factor-stimulated fat storing
cell proliferation
Platelet derived growth factor (0.5 §/1, 16.6 pmol/1)
was added, on the 2nd day after seeding to primary
cultures of fat storing cells grown in Dulbecco's mod-
ification of Eagle's medium without foetal calf serum.
Under these conditions, platelet derived growth factor
stimulated fat storing cells proliferation, äs measured
by [3H]thymidine incorporation, to a maximum of
2.1-fold compared with controls (tab. 2). The DNA
content was increased by platelet derived growth fac-
tor (2 g/l, 66 pmol/1) during 48 h of Stimulation to
1.24fold ofcontrol.
Synthesis and secretion of glycosaminogly-
cans by rat liver fat storing cells
Stimulation by thrombocyte lysate
Thrombocyte lysate caused a dose-dependent increase
(up to 8-fold) of the incorporation of [35S]sulphate
(per mg DNA) into the total proteoglycans of fat
storing cells grown in Dulbecco's modification of Ea-
gle's medium without foetal calf serum (fig. 7). There
was a preferential incorporation of [35S]sülphate into
the -proteoglycans of the medium (about 11-fold),
whereas proteoglycan radioactivity associated with
the cell layer increased only 4-fold in the presence of
lysate. When fat storing cells were cultured in Dul-
2.5'-
2,0







Fig. 5. Effect of transforming growth factor ß (TGFß) on ep-
idermal growth factor (EGF) stimulated fat stöfmg cell
proliferation measured by [3H]thymidme incöfporätiöiiu
Cells were seeded at a density of 0.06 l O6 cells/cm2
in 6 well culture plates and grown in Dulbecco's modi?
fication of Eagle's medium containing a fraction öf
0.005 foetal calf serum, The controls were cultures kept
in Dulbecco's modification of Eagle's medium contain-
ing a fraction of 0;005 foetal calf serum. Transfonning
growth factor ß was added simultanously with epider-
mal growth factor on the 2nd and 3^ day of culture.












Fig. 6. Effect of transforming growth factor ß ön fat storing
cell growtfi and transformation to desmin-positive myo-
fibrpblast-like cells. Cells were seeded at a density of
3 l O3 cells/cm2 and grown in Dulbecco's modification
of Eagle's medium containing a fraction of 0.1 foetal
calf serum in the presence [12] and absence [i§S] of
transforming growth factor ß. Transforming growth fac-
tor ß (20 pmol/1) was added on the Ist, 5th, 7th, 13th,
15th and 17th day of culture. Cultures were stopped on
the 2nd, 6th, 8th, 14th, 16th and 18th day after seeding.
In fig. 6a the black bars represent the number of desmin-
positive cells per cm2 in confcrol, the grey bars represent
the number of desmin-positive cells per cm? in trans-
forming growth factor ß-treated eultures. The inset b).
demonstrates the relative amount (fraction of total cells)
of desmin-positive cells in control (· -^ B) and in trans·1
forming growth factor ß-treated cultures (A — A). Total
cell numbers were counted using phase^conträst mi-
croscopy (see fig. Id) and desmin-positive cells were
counted using light microscopy after immunoperoxidase
staining for desmin (see fig. Ic). Mean vajues pf 2
representative experinients are given.
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Tab. 2. Effect of platelet-derived growth factor on fat storing cell proliferation measured by [3H]thymidine incorporation.
Cells were seeded at a density of 0.1 χ ΙΟ6 cells/cm2 in 6-well culture plates and kept in Dulbecco's modification of
Eagle's medium without foetal calf serum (PCS). Different coneentrations of platelet derived growth factor (0.25 — 5 μg/l)
were added on the 2nd and 3rd day of culture. Between the 3rd and 4th day cells were exposed for 24 h to [3H]thymidine
74 MBq/1 medium. The mean values ± SD of 4 cultures are shown.
[3H]thymidine incorporation (Bq/culture)
Control Platelet-derived growth factor [ug/1]
without PCS 0.25 0.5
11.7 ± 2.1 20.6 ± 4.8 24.5 ± 1.4 18.3 ± 2.3 19.6 ± 1.5
becco's modification of Eagle's medium containing a
fraction of 0.1 foetal calf serum, the stimulatory effect
of thrombocyte lysate on proteoglycan synthesis was
much weaker (only 2-fold), suggesting that the en-
hancement of proteoglycan synthesis by foetal calf
serum is largely due to platelet derived factors.
Epidermal growth factor-stimulatedglycosaminoglycan
synthesis
In the presence of 5 ml/l foetal calf serum, epidermal
growth factor significantly stimulated proteoglycan
synthesis, s measured by [35S]sulphate incorporation
in the proteoglycans of the medium. Epidermal
growth factor (3.3 nmol/1, 20 μg/l), stimulated
[35S]sulphate incorporation per culture 2.3-fold, and
per mg DNA 1.6-fold, c mpared with controls.
Transforming growth factor -stimulated glycosami-
noglycan synthesis
Treatment of fat storing cells with transforming
growth factor β caused a dose-dependent enhanced
radiosulphate incorporation into secreted (medium)
glycosaminoglycans, with a maximal increase of about
2-fold at 2.5 μg/l in Dulbecco's modification ofEagle's
medium containing 5 ml/l foetal calf serum (fig. 8a)
and a maximal increase of about 1.7 fold at l μg
transforming growth factor β per litre Dulbecco's
modification of Eagle's medium containing 100 ml/l
foetal calf serum (fig. 8b). In a preliminary experiment
we found that in controls (Dulbecco's modification of
Eagle's medium containing a fraction of 0.005 foetal
calf serum) most (75%) of the incorporated
[35S]sulphate was present in the dermatan-sulphate
fraction, whereas heparan-sulphate contained 20%
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Fig. 7. Effect of thrombocyte lysate on !i35S]sulphate incorpo-
- ration into glycosaminoglycans of cell layer and me-
dium, Thrombocyte lysate (0.65—2.6 mg protein/cul-
ture) was added on the second and on the third day
after seeding. Cells were seeded at a density of 0.1 χ ΙΟ6
cells/em?. Control cultures received Dulbecco's modifi-
cation of Eagle's medium without foetal calf serum.
After labelling for 24 h with [35S]sulphate (740 MBq/1
medium) glycosaminoglycans of cell· layer (α— α) and
medium (o —o) were analysed .separately. Values are
expressed s mean ± SD of three independent experi-
ments, each with n = 4 on the basis of DNA content.
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Fig. 8. Incorporation of [35S]sulphate into medium glycosami-
noglycans of fat storing cells grown in Dulbecco's mod-
ification of Eagle's medium containing a fraction of
0.005 (a) or 0.1 foetal calf serum (b), respectively. Cells
were seeded at a density of 0.06 χ l O6 cells/cm2 in 6-
well culture plates. Transforming growth factor β was
added on the 2nd and 3rd day after seeding. Between
the 3rd and 4th culture day cells were exposed for 24 h
to 740 MBq [35S]sulphate per litre medium. Values are
expressed s mean ± SD of 4 cultures on the basis of
DNA.
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phate. Addition of transforming growth factor β re-
duced the relative radiosulphate content of dermatan-
sulphate from 75% to 62%, and of heparan-sulphate
from 20 to 10%, but increased the relative
[35S]sulphate content of chondroitin-sulphate from 5
to 32%. In contrast to newly synthesized and secreted
dermatan-sulphate and heparan-sulphate, the abso-
lute [35S]sulphate incorporation, expressed s radio-
sulphate incorporation per mg DNA into chondro-
itin-sulphate, was also significantly stimulated by
transforming growth factor β (at 0.5 μg/l about 7-
fold and at 2.0 μg/l more than 8-fold) compared with
controls.
Effecl ofplatelet derived growth factor on glycosami-
noglycan synthesis
Platelet derived growth factor (0.25 — 5.0 μ§/1, 8.3 —
166 pmol/1), added on the 2nd day after seeding to
primary cultures of fat storing cells grown in Dulbec*·
co*s modification of Eagle's medium without or with
a fraction of 0.1 foetal calf serum, did not significantly
increase the quantity of glycosaminoglycan synthe-
sised per mg DNA.
Discussion
The ability of liver fat storing cells to proliferate
strongly (9, 11, 12), and to transform into myofi-
broblast-like cells (4,11,13) which produce significant
quantities of connective tissue components, is consid-
ered to be an important event in human and animal
ver fibrogenesis (l, 5, 7, 10, 16, 17, 18). Following
all types of hepatic injury, an Infiltration of the tissue
with blood monocytes occurs, and this is paralleled
by an enhanced proliferation of Kupffer cells (26)
followed by a stimulated proliferation and transfor-
mation of fat storing cells. These observations and
the electron microscopic demonstration of platelets
together with infiltrated inflammatory cells in liver
cell necrotic areas (20) support the hypothesis that
factors released from these cells might directly pro-
mote the growth, transformation and extracellular
matrix synthesis of fat storing cells.
Studies from others and from our laboratory support
this hypothesis. It was shown recently that secretions
of activated Kupffer cells and monocytes stimulate the
proliferation/transformation of fat storing cells in cul-
ture (9, 12), s well s the synthesis of proteoglycans
(16) and hyaluronic acid (10) by these cells. Compar-
ing the magnitude of matrix proteoglycan and hyalu-
ronate synthesis by fat storing cells with that of other
liver cells, it was concluded that the fat storing cell is
the most important cell in liver fibrogenesis (7). In
cultures of fat storing cells labelled for 24h with
[3H]glucosamine or [35S]sulphate, more than 70% of
the labelled glycosaminogiycans are found in the ex-
tracellular medium (7), At present, the function of the
s lphated glycosaminogiycans and other matrix ele-
ments seereted by fat storing cells is poorly under-
stood. Several authors propose that the interaction of
cells with the extracellular matfix influences cell be-
haviour, affecting cell adhesion and motility, growth
and differentiation (for review see 1. c. (27)). Impor-
tant new aspects of the putative functions of glycos-
aminogiycans are pr vided by observations showing
that type ΪΪΙ transforming growth factor β receptor
is a membrane heparan/chondroitin sulphate proteo-
glycan (28, 29) and that certain glycosaminogiycans
act s reservoirs of growth factors (30). However, we
have so far been unable to relate the high Output of
glycosaminogiycans by fat storing cells to specific
autocrine or paracrine effects.
In the present study we demonstrated for the first
time that platelets contain fibrogenic mediators which
stimulate not only proliferation, b t also the synthesis
and secretion of glycosaminogiycans into the extra-
cellular matrix by fat storing cells in primary culture.
The main growth factors elaborated by platelets are
transforming growth factor β (platelets are the riebest
source of transforming growth factor l (21)), platelet
derived growth factor (31) and epidermal growth fac-
tor (23). The data presented in this study clearly
demonstrate that primary cultures of rat fat storing
cells grown in Dulbecco's modification of Eagle's me-
dium containing a fraction of 0.005 foetal calf serum
show a mitogenic response to human epidermal
growth factor and platelet derived growth factor. Re-
cently, we demonstrated that the epidermal growth
factor-like transforming growth factor a, which is
produced by activated macrophages (19) and prob-
ably Kupffer cells (Bachern, unpublished data), binds
to epidermal growth factor receptor on fat storing
cells with a similar affinity to that of epidermal growth
factor, and stimulates the proliferation of fat storing
cells in culture (32). Epidermal growth factor and
transforming growth factor α are equally potent in
the Stimulation of fat storing cell proliferation.
Transforming growth factor , a MT = 25 000 disul-
phide-linked homodimer originally found in trans-
formed fibroblasts (21, 22) bel ngs to a family of
growth factors that regulate cell growth and differ-
entiation (for review see I.e. (33)). Transforming
growth factor β has been found to be both stimu-
lator (33, 34) and an inhibitor of cell growth (28, 33-
37) depending on the System studied. We showed that
transforming growth factor β strongly irihibited the
proliferation of fat storing cells stimulated by foetal
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calf serum or epidermal growth factor. Similar results,
i.e. a dose-dependent Inhibition of the epidermal
growth factor-stimulated proliferation, were obtained
with cultured rat aortic smooth muscle cells (37). As
proposed by Sporn et al. (38) and Roberts et al. (34)
transforming growth factor β stimulates or inhibits
proliferation s a function of the entire set of growth
factors present within the cell. Several in vitro studies
indicate that transforming growth factor β may con-
trol the effects of other polypeptide growth factors,
such s platelet derived growth factor, epidermal
growth factor/transforming growth factor a, basic
fibroblast growth factor and interleukin 2, and that
transforming growth factor β can determine whether
a cell responds in a positive or negative manner to
such a growth factor (for review see 1. c. (38)). This
action of transforming growth factor β seems to be
exerted via modulation of growth factor receptors,
since it was shown recently that transforming growth
factor β inhibits epidermal growth factor/transform-
ing growth factor α binding to the high affinity epi-
dermal growth factor cell surface receptors on fibro-
blasts (39), and furthermore that the platelet derived
growth factor-stimulated proliferation of bone mar-
row fibroblasts is also inhibited by interaction of
transforming growth factor β with platelet derived
growth factor binding (35).
In cultured normal human dermal fibroblasts trans-
forming growth factor β stimulates the synthesis of
types I and III collagens (40, 41) and fibronectin (40,
41, 42). In endothelial cells, fibronectin synthesis is
also stimulated by transforming growth factor β (36).
It is suggested that transforming growth factor β may
play a role in the normal regulation of extracell lar
matrix production in vivo, and may contribute to the
development of pathologic l states of skin (41) and
organ (43) fibrosis. The observation by Wiseman and
coworkers (44), that transforming growth factor β at
Very low concentrations (16—100 ng/1) may recruit
monocytes from the circulation and activate them to
express factors like tumour necrosis factor a, may
also by very relevant to fibrogenesis. Transforming
growth factor β stimulates Collagen synthesis in fat
storing cells (45). We show here for the first time that
transforming growth factor β added to primary cul-
tures of fat storing cells stimulates glycosaminoglycan
synthesis and extracell lar deposition of glycosami-
noglycans. In bovine cartilage organ cultures, trans-
forming growth factor β was also shown to regulate
the metabolism of glycosaminoglycans (46). Prelimi-
nary results showing that the synthesis of chondroitin
sulphate is preferentially stimulated by transforming
growth factor β agree with observations made by
others in mouse mammary epithelial cells (27).
Our results demonstrate that thrombocytes release
fibrogenic mediators which stimulate fat storing cell
proliferation/transformation and glycosaminoglycan
synthesis by these cells. All three polypeptide growth
factors studied (epidermal growth factor, platelet de-
rived growth factor and transforming growth factor
) are candidate mediators of platelet-derived fibro-
genic activity in culture, and in vivo during hepatic
injury. Others have shown that in acute CC14 liver
damage the level of transforming growth factor β
mRNA rises 24 h later and peaks at 48 h (47), and
that transforming growth factor β gene expression is
significantly enhanced during active fibrogenesis as-
sociated with liver disease in man (48). Together with
these observations, the results presented here indicate
a central, fundamental role for transforming growth
factor β in hepatic fibrogenesis.
Conclusion
The observation that activated Kupffer cells, mono-
cytes and thrombocytes, whose numbers are increased
in areas of liver cell injury, stimulate fat storing cell
proliferation/transformation and extracell lar matrix
synthesis, indicates the existence of cooperative inter-
actions between different hepatic and extrahepatic cell
types, mediated by paracrine mechanisms. These in-
teractions seem to be important in liver fibrogenesis,
a process in which transforming growth factor β may
play a central role.
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